The U.S. Food and Drug Administration (FDA) has just approved Levemir®, an insulin detemir [rDNA origin] injection, as the first and only basal insulin analog for Pregnancy Category B classification, which indicates that Levemir® does not pose a higher risk of harm for the unborn when used in pregnant women with diabetes. The drug is manufactured by Novo Nordisk... Original - http://www.medicalnewstoday.com/articles/243683.php
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন